At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 3, 2026 at 17:51 ET
Three C-suite insiders at Nurix Therapeutics (NRIX) sold a combined $539K of stock in a 7-day window, representing only ~0.02% of the $2.4B market cap. The sales coincide with option exercises and appear to be routine liquidity/tax-related transactions, not a negative signal on the company's prospects.
- Total open-market sales: $539K (0.02% of $2.4B market cap)
- Insiders: CFO van Houte, CSO Hansen, CLO Ring, all C-suite
- Sales follow option exercises at $0 or $8.72 strike, consistent with tax withholding / diversification
- No insider buying in the cluster, all activity is sell-side
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access